Skip to main content
https://pbs.twimg.com/media/FrhakZ_XgAAq6T-.jpg
IL-6 for PMR SPARE and SEMAPORE (Toci), SAPHYR (Sari) 2/2023: FDA approves sarilumab for PMR for inadequate response to corticosteroids or unable to taper off Robert Spiera @RheumNow #RNL2023 https://t.co/quOWjJjgB3
Eric Dein
18-03-2023
×